Aksan, Aysegül
Zepp, Fred
Anand, Sangeetha
Stein, Jürgen
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 8 April 2022
Revised: 24 June 2022
Accepted: 29 July 2022
First Online: 2 September 2022
Declarations
:
: Aysegül Aksan has received consultation fees and research funding from Vifor Pharma and Immundiagnostik AG. Sangeetha Anand is an employee of Vifor Pharma. Jürgen Stein has received consulting fees or honoraria from Abbvie, Bristol Myers Squibb, Dr. Schär, Falk, Ferring, Fresenius Kabi, Gallapagos, Immundiagnostik, Janssen, Medice, MSD, Pfizer, Pharmacosmos, Shire, Shield, Takeda, Thermo Fisher and Vifor Pharma. Fred Zepp is a member of the Data Safety Monitoring Boards (DSMB) for the development of COVID-19 vaccines (CureVac and Icosavax) and RS vaccines (Icosavax). He also serves as a DSMB observer for vaccine trials sponsored by CEPI.